SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
fibrosis
Journals
32
1
Scientific reports
2
The Journal of clinical investigation
3
Journal of magnetic resonance imaging : JMRI
4
annals of translational medicine
5
Trials
6
Aesthetic plastic surgery
7
trends in psychiatry and psychotherapy
8
European radiology
9
Indian journal of pediatrics
10
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
11
Obstetrics and gynecology
12
The Journal of surgical research
13
mucosal immunology
14
advances in experimental medicine and biology
15
faseb journal : official publication of the federation of american societies for experimental biology
16
bioscience, biotechnology, and biochemistry
17
Gut
18
Nature structural & molecular biology
19
Diagnostics (Basel, Switzerland)
20
sichuan da xue xue bao yi xue ban = journal of sichuan university medical science edition
21
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
22
gastroenterology
23
Biomedicines
24
annals of gastroenterology
25
the journal of toxicological sciences
26
sexual medicine
27
indonesian journal of biotechnology
28
the american journal on addictions
29
Infection and immunity
30
journal of orthopaedic research : official publication of the orthopaedic research society
31
the lancet hiv
32
jhep reports (online)
Research Groups
0
No Research Group Connected
Bibliographies
484
1
Inverse correlation of kidney interstitial cells expansion with hemoglobin level and erythropoietin expression in single and repeated kidney ischemic/reperfusion injury in mice
2
Liver Fibrosis Assessment with Diffusion-Weighted Imaging: Value of Liver Apparent Diffusion Coefficient Normalization Using the Spleen as a Reference Organ.
3
Antifibrotic and tumor microenvironment modulating effect of date palm fruit (Phoenix dactylifera L.) extracts in pancreatic cancer.
4
Clinical significance of the immune cell landscape in hepatocellular carcinoma patients with different degrees of fibrosis.
5
Self-care for head and neck cancer survivors with lymphedema and fibrosis: study protocol for a randomized controlled trial.
6
Novel contribution to clubfoot pathogenesis: The possible role of extracellular matrix proteins.
7
Intraperitoneal Administration of Telmisartan Prevents Postsurgical Adhesion Band Formation.
8
Yersiniabactin-Producing Adherent/Invasive Escherichia coli Promotes Inflammation-Associated Fibrosis in Gnotobiotic Mice.
9
Alda-1, an Aldehyde Dehydrogenase 2 Agonist, Improves Cutaneous Wound Healing by Activating Epidermal Keratinocytes via Akt/GSK-3β/β-Catenin Pathway.
10
Intestinal epithelial NAIP/NLRC4 restricts systemic dissemination of the adapted pathogen Salmonella Typhimurium due to site-specific bacterial PAMP expression.
11
Development and application of two novel monoclonal antibodies against overexpressed CD26 and integrin α3 in human pancreatic cancer.
12
The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositis.
13
Quantifying HIV transmission flow between high-prevalence hotspots and surrounding communities: a population-based study in Rakai, Uganda.
14
TGF-β1-p53 cooperativity regulates a profibrotic genomic program in the kidney: molecular mechanisms and clinical implications.
15
Codependency and Prefrontal Cortex Functioning: Preliminary Examination of Substance Use Disorder Impacted Family Members.
16
Dependency, mood instability, and inconsequence traits for discriminating borderline personality disorder.
17
Prevalence, Risk Factors, and Erectile Dysfunction Associated With Peyronie's Disease Among Men Seeking Urological Care.
18
Liver fibrosis and CD206 macrophage accumulation are suppressed by anti-GM-CSF therapy.
19
[The Therapeutic Effect and Mechanism of Static Progressive Stretching in Different Durations on Traumatic Knee Contracture in Rats].
20
Roneparstat: Development, Preclinical and Clinical Studies.
21
progressive subretinal fibrosis and multifocal granulomatous chorioretinitis fibrose sub-retiniana progressiva e corioretinite granulomatosa multifocal
22
wavelength and fibrosis affect phase singularity locations during atrial fibrillation
23
increased drp1-mediated mitochondrial fission promotes proliferation and collagen production by right ventricular fibroblasts in experimental pulmonary arterial hypertension
24
comparison of the suppressing capecitabine and 5-fluorouracil effects on the pronounce of inflammatory cells score in the induction of episcleral fibrosis after trabeculectomy
25
editorial: cardiac remodeling: new insights in physiological and pathological adaptations
26
targeting hypoxia inducible factors-1α as a novel therapy in fibrosis
27
diabetic cardiomyopathy: impact of biological sex on disease development and molecular signatures
28
nanoparticles for the treatment of liver fibrosis
29
attenuation of the hepatoprotective effects of ileal apical sodium dependent bile acid transporter (asbt) inhibition in choline-deficient l-amino acid-defined (cdaa) diet-fed mice
30
artroscopia diagnóstica e terapêutica em pacientes sintomáticos pós-artroplastia do joelho diagnostic and therapeutic arthroscopy in symptomatic patients after knee arthroplasty
31
dysregulated cd25 and cytokine expression by γδ t cells of systemic sclerosis patients stimulated with cardiolipin and zoledronate
32
surgical outcome of deep anterior lamellar keratoplasty with air-assisted manual dissection for corneas with previous inflammation or fibrosis
33
cellular and molecular mechanisms of chronic kidney disease with diabetes mellitus and cardiovascular diseases as its comorbidities
34
editorial: sedentary behavior in human health and disease
35
role of pancreatic stellate cells in chemoresistance in pancreatic cancer
36
place of needle biopsy in the diagnosis of chronic diffuse liver diseases
37
the hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels
38
expression and its significance of hypoxia-inducing factor-1α in rats with isoproterenol-induced atrial fibrosis
39
therapeutic potential of matrix metalloproteinases in duchenne muscular dystrophy
40
sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (nash) rodent model
41
biomarker-based approaches for assessing alcohol use disorders
42
case report of cirrhosis following yttrium-90 radioembolization for pancreatic neuroendocrine liver metastases
43
fibrosis: a structural modulator of sinoatrial node physiology and dysfunction
44
association between angiogenesis soluble factors and disease progression markers in chronic hepatitis c patients asociación entre factores angiogénicos solubles y marcadores de progresión de la enfermedad en pacientes con hepatitis crónica c
45
halofuginone — the multifaceted molecule
46
mesenchymal stem cells and serelaxin synergistically abrogate established airway fibrosis in an experimental model of chronic allergic airways disease
47
reduced kidney levels of lysophosphatidic acids in rats after chronic administration of aristolochic acid: its possible protective role in renal fibrosis
48
effect of iron overload on the severity of liver histologic alterations and on the response to interferon and ribavirin therapy of patients with hepatitis c infection
49
tissue remodeling in chronic eosinophilic esophageal inflammation: parallels in asthma and therapeutic perspectives
50
reprodutibilidade da classificação ultra-sonográfica de niamey na avaliação da fibrose periportal na esquistossomose mansônica reproducibility of ultrasonography in the assessment of periportal fibrosis according to niamey criteria in patients with schistosomiasis mansoni
51
increased connective tissue growth factor expression in a rat model of chronic heart allograft rejection
52
mechanisms of kidney injury in lupus nephritis - the role of anti-dsdna antibodies
53
heme oxygenase, inflammation, and fibrosis: the good, the bad, and the ugly?
54
the essential role of cytokinin signaling in root apical meristem formation during somatic embryogenesis
55
fibrosis progresiva del cuÁdriceps
56
Chronic Liver Disease - What's New?
57
Association Between Myocardial Oxygenation and Fibrosis in Duchenne Muscular Dystrophy: Analysis by Rest Oxygenation-Sensitive Magnetic Resonance Imaging.
58
The palisade layer of the poxvirus core is composed of flexible A10 trimers.
59
Spontaneous Epiretinal Membrane Resolution and Angiotensin Receptor Blockers: Case Observation, Literature Review and Perspectives.
60
TWIST1+FAP+ fibroblasts in the pathogenesis of intestinal fibrosis in Crohn's disease.
61
Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis.
62
Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis.
63
Long-term implant fibrosis prevention in rodents and non-human primates using crystallized drug formulations.
64
Wnt/β-catenin/RAS signaling mediates age-related renal fibrosis and is associated with mitochondrial dysfunction.
65
The antioxidant and DNA-repair enzyme apurinic/apyrimidinic endonuclease 1 limits the development of tubulointerstitial fibrosis partly by modulating the immune system
66
Design, synthesis, and antifibrosis evaluation of 4-(benzo-[c][1,2,5]thiadiazol-5-yl)-3(5)-(6-methyl- pyridin-2-yl)pyrazole and 3(5)-(6-methylpyridin- 2-yl)-4-(thieno-[3,2,-c]pyridin-2-yl)pyrazole derivatives.
67
Prediction and Staging of Hepatic Fibrosis in Children with Hepatitis C Virus: A Machine Learning Approach.
68
Genotypic characterization of Pseudomonas aeruginosa isolates from Turkish children with cystic fibrosis
69
Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: in vitro and in vivo studies
70
Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime–avibactam
71
Impact of concomitant nontuberculous mycobacteria and Pseudomonas aeruginosa isolates in non-cystic fibrosis bronchiectasis
72
Emergence and spread of worldwide Staphylococcus aureus clones among cystic fibrosis patients
73
Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy
74
Role of small colony variants in persistence of Pseudomonas aeruginosa infections in cystic fibrosis lungs
75
Discrepancy in MALDI-TOF MS identification of uncommon Gram-negative bacteria from lower respiratory secretions in patients with cystic fibrosis
76
Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients
77
Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis
78
Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis
79
Genotypic characterization of Pseudomonas aeruginosa isolates from Turkish children with cystic fibrosis
80
Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: in vitro and in vivo studies
81
Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime–avibactam
82
Impact of concomitant nontuberculous mycobacteria and Pseudomonas aeruginosa isolates in non-cystic fibrosis bronchiectasis
83
Emergence and spread of worldwide Staphylococcus aureus clones among cystic fibrosis patients
84
Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy
85
Role of small colony variants in persistence of Pseudomonas aeruginosa infections in cystic fibrosis lungs
86
Discrepancy in MALDI-TOF MS identification of uncommon Gram-negative bacteria from lower respiratory secretions in patients with cystic fibrosis
87
Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients
88
Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis
89
Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis
90
Variables Associated with a Urinary MicroRNAs Excretion Profile Indicative of Renal Fibrosis in Fabry Disease Patients
91
Oral Submucous Fibrosis in Pediatric Patients: A Systematic Review and Protocol for Management
92
Overview of idiopathic pulmonary fibrosis, evidence-based guidelines, and recent developments in the treatment landscape.
93
Adipose group 1 innate lymphoid cells promote adipose tissue fibrosis and diabetes in obesity
94
Singing as an adjunct therapy for children and adults with cystic fibrosis.
95
Opportunities to Improve Utilization of Palliative Care among Adults with Cystic Fibrosis: A Systematic Review.
96
Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?
97
Antler stem cells as a novel stem cell source for reducing liver fibrosis.
98
SETTING UP OF A HOMECARE SYSTEM FOR HIGH COST NEBULISERS IN A PAEDIATRIC CYSTIC FIBROSIS CENTRE.
99
OFDM-based electrical impedance spectroscopy technique for pacemaker-induced fibrosis detection implemented in an ARM microprocessor
100
Psychological predictors of nutritional adherence in adolescents with cystic fibrosis.
101
Serum fucose level in oral cancer, leukoplakia, and oral sub mucous fibrosis: A biochemical study.